TYLENOL W/ CODEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tylenol W/ Codeine, and what generic alternatives are available?
Tylenol W/ Codeine is a drug marketed by Ortho Mcneil Pharm and Janssen Pharms and is included in five NDAs.
The generic ingredient in TYLENOL W/ CODEINE is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tylenol W/ Codeine
A generic version of TYLENOL W/ CODEINE was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TYLENOL W/ CODEINE?
- What are the global sales for TYLENOL W/ CODEINE?
- What is Average Wholesale Price for TYLENOL W/ CODEINE?
Summary for TYLENOL W/ CODEINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 24 |
Patent Applications: | 4 |
DailyMed Link: | TYLENOL W/ CODEINE at DailyMed |
Recent Clinical Trials for TYLENOL W/ CODEINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eurofarma Laboratorios S.A. | Phase 3 |
University of Toronto | Phase 4 |
Humber River Hospital | Phase 4 |